2024
Hepatitis B vaccine birth dose coverage among hepatitis B-exposed and hepatitis B-unexposed infants: evidence from the Healthy Beginning Initiative program in Benue State, Nigeria
Olakunde B, Itanyi I, Onyeka T, Paintsil E, Torpey K, Lasebikan N, Chigbu C, Ezeanolue E. Hepatitis B vaccine birth dose coverage among hepatitis B-exposed and hepatitis B-unexposed infants: evidence from the Healthy Beginning Initiative program in Benue State, Nigeria. Pan African Medical Journal 2024, 47: 67. PMID: 38681098, PMCID: PMC11055182, DOI: 10.11604/pamj.2024.47.67.40466.Peer-Reviewed Original ResearchHepB-BDAntenatal careInfants of mothersSecondary analysis of dataInstitutional deliveryHepB-BD coverageInitial programBirth dose coverageObstetric factorsSociodemographic characteristicsLess-educated mothersSecondary analysisControl of hepatitis BDose coverageAnalysis of dataPost-delivery surveysImmunization questionsHepatitis BHealthyCareHepBInfantsMothersHepatitisWomen
2023
Pediatric HIV Disclosure Intervention Improves Immunologic Outcome at 48 Weeks: The Sankofa Trial Experience
Shabanova V, Emuren L, Gan G, Antwi S, Renner L, Amissah K, Kusah J, Lartey M, Reynolds N, Paintsil E. Pediatric HIV Disclosure Intervention Improves Immunologic Outcome at 48 Weeks: The Sankofa Trial Experience. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2023, 94: 371-380. PMID: 37643414, PMCID: PMC10617661, DOI: 10.1097/qai.0000000000003292.Peer-Reviewed Original ResearchConceptsHIV disclosure interventionsVirologic outcomesCD4 percentWeek 48HIV statusIntervention groupHIV disclosureDisclosure interventionDetectable viral loadWorld Health OrganizationAntiretroviral therapyImmunologic outcomesClinical outcomesIntervention armViral loadControl armClinical trialsTrial experienceSecondary analysisDisclosure statusHealth OrganizationCategorical variablesWeeksLinear mixed modelsBaseline